Peroxisome proliferator-activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axisLiang Qin(Tongji Hospital), Hui Liao(Huazhong University of Science and Technology)Molecular Medicine ReportsMay 13, 201410.3892/mmr.2014.2232Cited by 38SaveCiteExport RISWatch citationsRelated PapersGinsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K/AKT/mTOR pathway|Die Pharmazie|2018|42Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway|Molecular Medicine Reports|2014|28